Learn more

UNIV LILLE

Overview
  • Total Patents
    61
  • GoodIP Patent Rank
    24,879
  • Filing trend
    ⇧ 175.0%
About

UNIV LILLE has a total of 61 patent applications. It increased the IP activity by 175.0%. Its first patent ever was published in 2011. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are UNIV BRISTOL, TRINITY COLLEGE DUBLIN and WISCONSIN ALUMNI RES FOUND.

Patent filings per year

Chart showing UNIV LILLEs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Vlandas Alexis 9
#2 Cappy Alain 8
#3 Loyez Christophe 8
#4 Senez Vincent 7
#5 Sourikopoulos Ilias 6
#6 Baudoin Michaël 6
#7 Thomas Jean-Louis Pierre 5
#8 Danneville Francois 5
#9 Cosson Michel 4
#10 Bou Matar-Lacaze Olivier Khalil Nizar 4

Latest patents

Publication Filing date Title
WO2020245216A1 Novel lactic acid bacteria strain - antibacterial peptides produced by said strain and related pharmaceutical compositions
WO2020207793A1 Cutaneous device for storing and releasing molecules, and corresponding method
WO2020148403A1 5-membered heteroaryl compounds containing a hydroxamate moiety and their use
WO2019102167A1 Continuous acoustic monitoring device and corresponding method
US2020338593A1 Acoustic tweezers
CA3065459A1 Optical detection method
CA3065406A1 Optical detection method
FR3081073A1 ARTIFICIAL SYNAPSE SWITCHED
CA3052686A1 Method for determining the mechanical properties of a pelvic cavity, and measuring device
EP3535737A1 Trolley or other container including means for optimally determining in real-time the contents thereof
US2019130258A1 Artificial neuron
EP3430002A1 Furoic acid preparation method
CA3007721A1 Method for increasing the ability of at least one droplet to slide over a medium
EP3317326A1 Method for the production of hydrogel comprising chitosan and negatively charged polyelectrolytes, and cellular, porous material resulting from said hydrogel
EP3256583A1 Method for producing dna vectors from molecular bricks containing sequences of interest
EP3152234A2 Antibody which is directed against galectin-9 and is an inhibitor of the suppressor activity of regulatory t lymphocytes
EP3060803A1 Method for generating a flow of fluid
EP2600865A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound